About this trial
This study aims to evaluate the effectiveness and usability of HEMImprove 1.0, a gamified mobile application designed to improve upper limb motor function in adolescents with unilateral cerebral palsy. Participants will be randomly assigned to an intervention group using the app or a control group performing conventional home exercises. The intervention will last four weeks, with assessments before and after the intervention to measure motor function, motivation, and quality of life improvements.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adolescents aged 12 to 18 years diagnosed with unilateral cerebral palsy.
Ability to use the mobile app independently or with minimal assistance.
Informed consent provided.
Disqualifiers
Severe cognitive impairment.
Recent upper limb surgery (within 6 months).
Recent botulinum toxin treatment (within 3 months).
Other neurological or orthopedic disorders affecting upper limb function.
Trial design
Parallel
Treatments tested in this trial
HEMImprove APP
Other interventionExperimental Group: Use HEMImprove 1.0 mobile app at home for 30 minutes/session, 5 days/week, for 4 weeks. Exercises tailored progressively with avatar guidance. Control Group: Perform conventional home exercises guided by printed manual with instructions and images, matching frequency and duration of intervention group.
exercises to upper limb
Other interventionThe patients will do the same exercises than the experimental group, without APP and using the same dosage
Treatment groups
Trial outcomes
Primary outcomes
Assisting Hand Assessment
Melbourne Assessment v 2.0 MA2
Nine hole Test
Secondary outcomes
User satisfaction and usability measured through structured Likert-scale questionnaires post-intervention.
Qualitative data from semi-structured interviews analyzing user experience.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: